Charles & Colvard Ltd. (CTHR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Charles & Colvard Ltd.

    NASDAQ: CTHR · Real-Time Price · USD
    0.70
    0.00 (0.00%)
    At close: Oct 01, 2025, 11:38 AM
    0.70
    0.00%
    Pre-market: Oct 01, 2025, 11:38 AM EDT

    Charles & Colvard Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 21.96M 29.95M 43.09M 39.24M
    Cost of Revenue
    		 16.76M 25.21M 22.85M 20.81M
    Gross Profit
    		 5.19M 4.73M 20.24M 18.43M
    Operating Income
    		 -14.61M -13.98M 2.87M 5.51M
    Interest Income
    		 300.72K 297.26K 19.28K 5.58K
    Pretax Income
    		 -14.36M -13.68M 2.89M 6.48M
    Net Income
    		 -14.36M -19.58M 2.37M 12.81M
    Selling & General & Admin
    		 18.32M 18.71M 17.37M 12.92M
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 1.47M n/a n/a n/a
    Operating Expenses
    		 19.8M 18.71M 17.37M 12.92M
    Interest Expense
    		 57.72K n/a n/a 8.95K
    Selling & Marketing Expenses
    		 12.55M 13.69M 12.42M 8.48M
    Cost & Expenses
    		 36.56M 43.92M 40.22M 33.73M
    Income Tax Expense
    		 n/a 5.9M 518.53K -6.33M
    Shares Outstanding (Basic)
    		 3.03M 3.04M 3.04M 3.05M
    Shares Outstanding (Diluted)
    		 3.03M 3.04M 3.13M 3.02M
    EPS (Basic)
    		 -4.73 -6.45 0.78 4.40
    EPS (Diluted)
    		 -4.73 -6.45 0.78 4.20
    EBITDA
    		 -14.61M -13.03M 3.35M 6.23M
    EBIT
    		 -14.42M -13.68M 2.87M 6.49M
    Depreciation & Amortization
    		 -185.28K 653.16K 479.31K 567.12K

    Add to Watchlist